Literature DB >> 22432704

Rga, a RofA-like regulator, is the major transcriptional activator of the PI-2a pilus in Streptococcus agalactiae.

Shaynoor Dramsi1, Sarah Dubrac, Yoan Konto-Ghiorghi, Violette Da Cunha, Elisabeth Couvé, Philippe Glaser, Elise Caliot, Michel Débarbouillé, Samuel Bellais, Patrick Trieu-Cuot, Michel-Yves Mistou.   

Abstract

Rapid adaptation to changing environments is key in determining the outcome of infections caused by the opportunistic human pathogen Streptococcus agalactiae. We previously demonstrated that the RofA-like protein (RALP) regulators RogB and Rga activate their downstream divergently transcribed genes, that is, the pilus operon PI-2a and the serine-rich repeat encoding gene srr1, respectively. Characterization of the Rga regulon by microarray revealed that the PI-2a pilus was strongly controlled by Rga, a result confirmed at the protein level. Complementation experiments showed that the expression of Rga, but not RogB, in the double ΔrogB/Δrga mutant, or in the clinical strain 2603V/R displaying frameshift mutations in rogB and rga genes, is sufficient to restore wild-type expression levels of PI-2a pilus and Srr1. Biofilm formation was impaired in the Δrga and Δrga/rogB mutants and restored on complementation with rga. Paradoxically, adherence to intestinal epithelial cells was unchanged in the Δrga mutant. Finally, the existence of several clinical isolates mutated in rga highlights the concept of strain-specific regulatory networks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22432704     DOI: 10.1089/mdr.2012.0005

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

Review 1.  The Double Life of Group B Streptococcus: Asymptomatic Colonizer and Potent Pathogen.

Authors:  Blair Armistead; Elizabeth Oler; Kristina Adams Waldorf; Lakshmi Rajagopal
Journal:  J Mol Biol       Date:  2019-01-31       Impact factor: 5.469

2.  FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions.

Authors:  Marco Buscetta; Salvatore Papasergi; Arnaud Firon; Giampiero Pietrocola; Carmelo Biondo; Giuseppe Mancuso; Angelina Midiri; Letizia Romeo; Giuseppe Teti; Pietro Speziale; Patrick Trieu-Cuot; Concetta Beninati
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

3.  The Abi-domain protein Abx1 interacts with the CovS histidine kinase to control virulence gene expression in group B Streptococcus.

Authors:  Arnaud Firon; Asmaa Tazi; Violette Da Cunha; Sophie Brinster; Elisabeth Sauvage; Shaynoor Dramsi; Douglas T Golenbock; Philippe Glaser; Claire Poyart; Patrick Trieu-Cuot
Journal:  PLoS Pathog       Date:  2013-02-21       Impact factor: 6.823

4.  Phenotypical analysis of the Lactobacillus rhamnosus GG fimbrial spaFED operon: surface expression and functional characterization of recombinant SpaFED pili in Lactococcus lactis.

Authors:  Johanna Rintahaka; Xia Yu; Ravi Kant; Airi Palva; Ingemar von Ossowski
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

5.  Increasing Resistance and Changes in Distribution of Serotypes of Streptococcus agalactiae in Poland.

Authors:  Dorota Kaminska; Magdalena Ratajczak; Anna Szumała-Kąkol; Jolanta Dlugaszewska; Dorota M Nowak-Malczewska; Marzena Gajecka
Journal:  Pathogens       Date:  2020-06-29

6.  Reductive evolution in Streptococcus agalactiae and the emergence of a host adapted lineage.

Authors:  Isabelle Rosinski-Chupin; Elisabeth Sauvage; Barbara Mairey; Sophie Mangenot; Laurence Ma; Violette Da Cunha; Christophe Rusniok; Christiane Bouchier; Valérie Barbe; Philippe Glaser
Journal:  BMC Genomics       Date:  2013-04-15       Impact factor: 3.969

7.  Evidence for the Sialylation of PilA, the PI-2a Pilus-Associated Adhesin of Streptococcus agalactiae Strain NEM316.

Authors:  Eric Morello; Adeline Mallet; Yoan Konto-Ghiorghi; Thibault Chaze; Michel-Yves Mistou; Giulia Oliva; Liliana Oliveira; Anne-Marie Di Guilmi; Patrick Trieu-Cuot; Shaynoor Dramsi
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.